HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
801	9924 Wong PC, Cai HB, Borchelt DR, Price DL Genetically engineered models relevant to neurodegenerative disorders - Their value for understanding disease mechanisms and designing/testing experimental therapeutics JOURNAL OF MOLECULAR NEUROSCIENCE. 2001 OCT; 17 (2): 233-257	5	8	38	211
802	14375 Kontush A Apolipoprotein A beta: Black sheep in a good family BRAIN PATHOLOGY. 2004 OCT; 14 (4): 433-447	3	9	24	211
803	16123 Carson RG Neural pathways mediating bilateral interactions between the upper limbs BRAIN RESEARCH REVIEWS. 2005 NOV; 49 (3): 641-662	0	87	4	211
804	16536 Lang AE, Houeto JL, Krack P, Kubu C, Lyons KE, et al. Deep brain stimulation: Preoperative issues MOVEMENT DISORDERS. 2006; 21: S171-S196	2	39	4	211
805	18422 Thomas P, Fenech M A review of genome mutation and Alzheimer's disease MUTAGENESIS. 2007 JAN; 22 (1): 15-33	0	18	36	211
806	21342 Andres RH, Ducraya AD, Schlattner U, Wallimann T, Widmer HR Functions and effects of creatine in the central nervous system BRAIN RESEARCH BULLETIN. 2008 JUL 1; 76 (4): 329-343	2	31	15	211
807	21999 Gorman AM Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2008 DEC; 12 (6A): 2263-2280	9	23	37	211
808	5649 Gasparini L, Racchi M, Binetti G, Trabucchi M, Solerte SB, et al. Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease FASEB JOURNAL. 1998 JAN; 12 (1): 17-34	18	113	22	210
809	5824 Savitz SI, Rosenbaum DM Apoptosis in neurological disease NEUROSURGERY. 1998 MAR; 42 (3): 555-572	17	80	2	210
810	6570 Goodrich LV, Scott MP Hedgehog and Patched in neural development and disease NEURON. 1998 DEC; 21 (6): 1243-1257	4	165	3	210
#	Date / Author / Journal	LCS	GCS	LCR	CR
811	7570 Margolis RL, McInnis MG, Rosenblatt A, Ross CA Trinucleotide repeat expansion and neuropsychiatric disease ARCHIVES OF GENERAL PSYCHIATRY. 1999 NOV; 56 (11): 1019-1031	2	50	7	210
812	11667 Murthy VN, De Camilli P Cell biology of the presynaptic terminal ANNUAL REVIEW OF NEUROSCIENCE. 2003; 26: 701-728	12	163	2	210
813	16956 Hodges BL, Cheng SH Cell and gene-based therapies for the lysosomal storage diseases CURRENT GENE THERAPY. 2006 APR; 6 (2): 227-241	1	17	4	210
814	17288 Schmidt-Kastner R, van Os J, Steinbusch HWM, Schmitz C Gene regulation by hypoxia and the neurodevelopmental origin of schizophrenia SCHIZOPHRENIA RESEARCH. 2006 JUN; 84 (2-3): 253-271	6	33	21	210
815	18284 O'Tuathaigh CMP, Babovic D, O'Meara G, Clifford JJ, Croke DT, et al. Susceptibility genes for schizophrenia: Characterisation of mutant mouse models at the level of phenotypic behaviour NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2007; 31 (1): 60-78	12	61	11	210
816	18970 Petrukhin K New therapeutic targets in atrophic age-related macular degeneration EXPERT OPINION ON THERAPEUTIC TARGETS. 2007 MAY; 11 (5): 625-639	0	18	6	210
817	19485 Hernandez F, Avila J Tauopathies CELLULAR AND MOLECULAR LIFE SCIENCES. 2007 SEP; 64 (17): 2219-2233	25	40	121	210
818	22518 Vandenbosch R, Borgs L, Beukelaers P, Belachew S, Moonen G, et al. Adult Neurogenesis and the Diseased Brain CURRENT MEDICINAL CHEMISTRY. 2009 FEB; 16 (6): 652-666	0	5	10	210
819	26215 Ali YO, Kitay BM, Zhai RG Dealing with Misfolded Proteins: Examining the Neuroprotective Role of Molecular Chaperones in Neurodegeneration MOLECULES. 2010 OCT; 15 (10): 6859-6887	0	0	35	210
820	26776 Marschall ALJ, Frenzel A, Schirrmann T, Schungel M, Dubel S Targeting antibodies to the cytoplasm MABS. 2011 JAN-FEB; 3 (1): 3-16	0	0	2	210
#	Date / Author / Journal	LCS	GCS	LCR	CR
821	881 FUKUSHIMA K THE INTERSTITIAL NUCLEUS OF CAJAL AND ITS ROLE IN THE CONTROL OF MOVEMENTS OF HEAD AND EYES PROGRESS IN NEUROBIOLOGY. 1987; 29 (2): 107-&	8	148	8	209
822	3303 DUARTE EA, NOVELLA IS, WEAVER SC, DOMINGO E, WAINHOBSON S, et al. RNA VIRUS QUASI-SPECIES - SIGNIFICANCE FOR VIRAL DISEASE AND EPIDEMIOLOGY INFECTIOUS AGENTS AND DISEASE-REVIEWS ISSUES AND COMMENTARY. 1994 AUG; 3 (4): 201-214	0	99	2	209
823	6122 Mastrianni JA The prion diseases: Creutzfeldt-Jakob, Gerstmann-Straussler-Scheinker, and related disorders JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY. 1998 SUM; 11 (2): 78-97	5	10	8	209
824	9635 Gotz J Tau and transgenic animal models BRAIN RESEARCH REVIEWS. 2001 JUL; 35 (3): 266-286	71	87	135	209
825	12748 Rensink AAM, de Waal RMW, Kremer B, Verbeek MM Pathogenesis of cerebral amyloid angiopathy BRAIN RESEARCH REVIEWS. 2003 OCT; 43 (2): 207-223	6	52	21	209
826	15249 Morris JC Dementia update 2005 ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2005 APR-JUN; 19 (2): 100-117	5	20	36	209
827	20925 Vanlangenakker N, Vanden Berghe T, Krysko DV, Festjens N, Vandenabeele P Molecular mechanisms and pathophysiology of necrotic cell death CURRENT MOLECULAR MEDICINE. 2008 MAY; 8 (3): 207-220	2	50	11	209
828	21153 Barten DM, Albright CF Therapeutic strategies for Alzheimer's disease MOLECULAR NEUROBIOLOGY. 2008 JUN; 37 (2-3): 171-186	7	39	54	209
829	23150 Berth SH, Leopold PL, Morfini G Virus-induced neuronal dysfunction and degeneration FRONTIERS IN BIOSCIENCE. 2009 JUN; 14: 5239-5259	1	2	8	209
830	25120 Hoffner G, Andre W, Vanhoutteghem A, Soues S, Djian P Transglutaminase-Catalyzed Crosslinking in Neurological Disease: From Experimental Evidence to Therapeutic Inhibition CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 APR; 9 (2): 217-231	0	0	46	209
#	Date / Author / Journal	LCS	GCS	LCR	CR
831	26243 Hamby ME, Sofroniew MV Reactive Astrocytes As Therapeutic Targets for CNS Disorders NEUROTHERAPEUTICS. 2010 OCT; 7 (4): 494-506	0	0	10	209
832	14758 Upadhya SC, Hegde AN Ubiquitin-proteasome pathway components as therapeutic targets for CNS maladies CURRENT PHARMACEUTICAL DESIGN. 2005; 11 (29): 3807-3828	2	9	53	208
833	17782 Muller N, Schwarz M Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission NEUROTOXICITY RESEARCH. 2006 OCT; 10 (2): 131-148	2	36	4	208
834	18009 McCudden CR, Kraus VB Biochemistry of amino acid racemization and clinical application to musculoskeletal disease CLINICAL BIOCHEMISTRY. 2006 DEC; 39 (12): 1112-1130	1	11	7	208
835	21312 Bhidayasiri R, Ling H Multiple system atrophy NEUROLOGIST. 2008 JUL; 14 (4): 224-237	1	4	22	208
836	24332 Joers VL, Emborg ME Preclinical Assessment of Stem Cell Therapies for Neurological Diseases ILAR JOURNAL. 2010; 51 (1): 24-41	0	3	31	208
837	24503 Krieg R, Halbhuber KJ Detection of endogenous and immuno-bound peroxidase - The status Quo in histochemistry PROGRESS IN HISTOCHEMISTRY AND CYTOCHEMISTRY. 2010; 45 (2): 81-139	0	0	2	208
838	25800 Robinson PA Understanding the molecular basis of Parkinson's disease, identification of biomarkers and routes to therapy EXPERT REVIEW OF PROTEOMICS. 2010 AUG; 7 (4): 565-578	0	1	87	208
839	531 MIETTINEN M, LEHTO VP, VIRTANEN I ANTIBODIES TO INTERMEDIATE FILAMENT PROTEINS IN THE DIAGNOSIS AND CLASSIFICATION OF HUMAN-TUMORS ULTRASTRUCTURAL PATHOLOGY. 1984; 7 (2-3): 83-107	23	163	6	207
840	2603 CRUTCHER KA, ANDERTON BH, BARGER SW, OHM TG, SNOW AD CELLULAR AND MOLECULAR PATHOLOGY IN ALZHEIMERS-DISEASE HIPPOCAMPUS. 1993; 3: 271-287	2	13	21	207
#	Date / Author / Journal	LCS	GCS	LCR	CR
841	3068 NAGLE RB A REVIEW OF INTERMEDIATE FILAMENT BIOLOGY AND THEIR USE IN PATHOLOGICAL DIAGNOSIS MOLECULAR BIOLOGY REPORTS. 1994 JAN; 19 (1): 3-21	4	38	3	207
842	3140 AVILA J, DOMINGUEZ J, DIAZNIDO J REGULATION OF MICROTUBULE DYNAMICS BY MICROTUBULE-ASSOCIATED PROTEIN EXPRESSION AND PHOSPHORYLATION DURING NEURONAL DEVELOPMENT INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY. 1994 MAR; 38 (1): 13-25	31	121	44	207
843	9995 Morley KI, Montgomery GW The genetics of cognitive processes: Candidate genes in humans and animals BEHAVIOR GENETICS. 2001 NOV; 31 (6): 511-531	1	19	8	207
844	12661 Batchelor PE, Howells DW CNS regeneration: clinical possibility or basic science fantasy? JOURNAL OF CLINICAL NEUROSCIENCE. 2003 SEP; 10 (5): 523-534	0	9	12	207
845	14892 Aksenova MV, Aksenov MY, Mactutus CF, Booze RM Cell culture models of oxidative stress and injury in the central nervous system CURRENT NEUROVASCULAR RESEARCH. 2005 JAN; 2 (1): 73-89	1	17	22	207
846	17785 Williams BJ, Eriksdotter-Jonhagen M, Granholm AC Nerve growth factor in treatment and pathogenesis of Alzheimer's disease PROGRESS IN NEUROBIOLOGY. 2006 OCT; 80 (3): 114-128	4	27	14	207
847	22984 Le Strat Y, Ramoz N, Gorwood P The Role of Genes Involved in Neuroplasticity and Neurogenesis in the Observation of a Gene-Environment Interaction (GxE) in Schizophrenia CURRENT MOLECULAR MEDICINE. 2009 MAY; 9 (4): 506-518	1	4	23	207
848	1992 MARGOLIN DI COGNITIVE NEUROPSYCHOLOGY - RESOLVING ENIGMAS ABOUT WERNICKES APHASIA AND OTHER HIGHER CORTICAL DISORDERS ARCHIVES OF NEUROLOGY. 1991 JUL; 48 (7): 751-765	0	17	2	206
849	3307 MANI S, MODLIN IM, BALLANTYNE G, AHLMAN H, WEST B CARCINOIDS OF THE RECTUM JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. 1994 AUG; 179 (2): 231-248	1	52	1	206
850	14062 Gotz J, Streffer JR, David D, Schild A, Hoerndli F, et al. Transgenic animal models of Alzheimer's disease and related disorders: Histopathology, behavior and therapy MOLECULAR PSYCHIATRY. 2004 JUL; 9 (7): 664-683	58	101	83	206
#	Date / Author / Journal	LCS	GCS	LCR	CR
851	16862 Fleischer A, Ghadiri A, Dessauge F, Duhamel M, Rebollo MP, et al. Modulating apoptosis as a target for effective therapy MOLECULAR IMMUNOLOGY. 2006 MAR; 43 (8): 1065-1079	0	28	6	206
852	20202 Dohm CP, Kermer P, Bahr M Aggregopathy in neurodegenerative diseases: Mechanisms and therapeutic implication NEURODEGENERATIVE DISEASES. 2008; 5 (6): 321-338	1	6	83	206
853	20629 Sakakibara R, Uchiyama T, Yamanishi T, Shirai K, Hattori T Bladder and bowel dysfunction in Parkinson's disease JOURNAL OF NEURAL TRANSMISSION. 2008 MAR; 115 (3): 443-460	1	9	1	206
854	21098 Venugopal C, Demos CM, Rao KSJ, Pappolla MA, Sambamurti K Beta-Secretase: Structure, Function, and Evolution CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2008 JUN; 7 (3): 278-294	1	3	14	206
855	21355 Singh M, Arseneault M, Sanderson T, Murthy V, Ramassamy C Challenges for research on polyphenols from foods in Alzheimer's disease: Bioavailability, metabolism, and cellular and molecular mechanisms JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY. 2008 JUL 9; 56 (13): 4855-4873	2	44	16	206
856	24908 Delcroix GJR, Schiller PC, Benoit JP, Montero-Menei CN Adult cell therapy for brain neuronal damages and the role of tissue engineering BIOMATERIALS. 2010 MAR; 31 (8): 2105-2120	0	6	29	206
857	24918 Luebke J, Barbas H, Peters A Effects of normal aging on prefrontal area 46 in the rhesus monkey BRAIN RESEARCH REVIEWS. 2010 MAR; 62 (2): 212-232	0	2	35	206
858	26600 Rupprecht R, Papadopoulos V, Rammes G, Baghai TC, Fan JJ, et al. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders NATURE REVIEWS DRUG DISCOVERY. 2010 DEC; 9 (12): 971-988	0	0	6	206
859	6078 Bischoff KM, Shi L, Kennelly PJ The detection of enzyme activity following sodium dodecyl sulfate- polyacrylamide gel electrophoresis ANALYTICAL BIOCHEMISTRY. 1998 JUN 15; 260 (1): 1-17	0	37	2	205
860	10210 Herz J, Bock HH Lipoprotein receptors in the nervous system ANNUAL REVIEW OF BIOCHEMISTRY. 2002; 71: 405-434	3	192	13	205
#	Date / Author / Journal	LCS	GCS	LCR	CR
861	11688 Festoff BW, Suo ZM, Citron BA Prospects for the pharmacotherapy of amyotrophic lateral sclerosis - Old strategies and new paradigms for the third millennium CNS DRUGS. 2003; 17 (10): 699-717	1	11	51	205
862	11718 Schallert T, Woodlee MT, Fleming SM Experimental focal ischemic injury: Behavior-brain interactions and issues of animal handling and housing ILAR JOURNAL. 2003; 44 (2): 130-143	1	11	4	205
863	12646 Uversky VN Protein folding revisited. A polypeptide chain at the folding- misfolding-nonfolding cross-roads: which way to go? CELLULAR AND MOLECULAR LIFE SCIENCES. 2003 SEP; 60 (9): 1852-1871	17	102	21	205
864	17720 Kyttala A, Lahtinen U, Braulke T, Hofmann SL Functional biology of the neuronal ceroid lipofuscinoses (NCL) proteins BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2006 OCT; 1762 (10): 920-933	0	35	2	205
865	18651 Hunter RL, Bing GY Agonism of peroxisome proliferator receptor-gamma may have therapeutic potential for neuroinflammation and Parkinson's disease CURRENT NEUROPHARMACOLOGY. 2007 MAR; 5 (1): 35-46	0	1	11	205
866	23924 Bulat N, Widmann C Caspase substrates and neurodegenerative diseases BRAIN RESEARCH BULLETIN. 2009 OCT 28; 80 (4-5): 251-267	1	3	47	205
867	26786 Scherder E, Eggermont L, Visscher C, Scheltens P, Swaab D Understanding higher level gait disturbances in mild dementia in order to improve rehabilitation: 'Last in-first out' NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2011 JAN; 35 (3): 699-714	0	0	17	205
868	1826 SKALLI O, GOLDMAN RD RECENT INSIGHTS INTO THE ASSEMBLY, DYNAMICS, AND FUNCTION OF INTERMEDIATE FILAMENT NETWORKS CELL MOTILITY AND THE CYTOSKELETON. 1991; 19 (2): 67-79	17	155	2	204
869	2628 FREED WJ NEURAL TRANSPLANTATION - PROSPECTS FOR CLINICAL USE CELL TRANSPLANTATION. 1993 JAN-FEB; 2 (1): 13-31	4	30	10	204
870	6860 Peckys D, Landwehrmeyer GB Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: A P-33 in situ hybridization study NEUROSCIENCE. 1999 FEB; 88 (4): 1093-1135	1	76	3	204
#	Date / Author / Journal	LCS	GCS	LCR	CR
871	8797 Alisky JM, Davidson BL Gene therapy for amyotrophic lateral sclerosis and other motor neuron diseases HUMAN GENE THERAPY. 2000 NOV; 11 (17): 2315-2329	4	25	16	204
872	10786 Okereke CS Role of integrative pharmacokinetic and pharmacodynamic optimization strategy in the management of Parkinson's disease patients experiencing motor fluctuations with levodopa. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES. 2002 MAY-AUG; 5 (2): 146-161	0	8	4	204
873	11810 Stein TD, Johnson JA Genetic programming by the proteolytic fragments of the amyloid precursor protein: Somewhere between confusion and clarity REVIEWS IN THE NEUROSCIENCES. 2003; 14 (4): 317-341	2	9	39	204
874	12744 Czyz J, Wiese C, Rolletschek A, Blyszczuk P, Cross M, et al. Potential of embryonic and adult stem cells in vitro BIOLOGICAL CHEMISTRY. 2003 OCT-NOV; 384 (10-11): 1391-1409	1	55	9	204
875	12772 Uversky VN A protein-chameleon: Conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS. 2003 OCT; 21 (2): 211-234	91	140	57	204
876	13091 Riddle R, Pollock JD Making connections: the development of mesencephalic dopaminergic neurons DEVELOPMENTAL BRAIN RESEARCH. 2003 DEC 30; 147 (1-2): 3-21	5	27	8	204
877	14204 Haddad JJ Mitogen-activated protein kinases and the evolution of Alzheimer's: a revolutionary neurogenetic axis for therapeutic intervention? PROGRESS IN NEUROBIOLOGY. 2004 AUG; 73 (5): 359-377	3	22	41	204
878	14725 Hughes CE, Baldus M Magic-angle-spinning solid-state NMR applied to polypeptides and proteins ANNUAL REPORTS ON NMR SPECTROSCOPY, VOL 55. 2005; 55: 121-158	0	16	1	204
879	17870 Barber SC, Mead RJ, Shaw PJ Oxidative stress in ALS: A mechanism of neurodegeneration and a therapeutic target BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2006 NOV-DEC; 1762 (11-12): 1051-1067	29	86	30	204
880	20388 Adibhatla RM, Dempsy R, Hatcher JF Integration of cytokine biology and lipid metabolism in stroke FRONTIERS IN BIOSCIENCE. 2008 JAN 1; 13: 1250-1270	1	13	4	204
#	Date / Author / Journal	LCS	GCS	LCR	CR
881	21682 Ono K, Hirohata M, Yamada M alpha-Synuclein Assembly as a Therapeutic Target of Parkinson's Disease and Related Disorders CURRENT PHARMACEUTICAL DESIGN. 2008 OCT; 14 (30): 3247-3266	5	13	75	204
882	22331 Kang SS, McGavern DB Inflammation on the Mind: Visualizing Immunity in the Central Nervous System VISUALIZING IMMUNITY. 2009; 334: 227-263	0	0	6	204
883	22432 Schwartz EI Potential application of RNAi for understanding and therapy of neurodegenerative diseases FRONTIERS IN BIOSCIENCE. 2009 JAN 1; 14: 297-320	2	3	20	204
884	24370 Martin LJ Mitochondrial Pathobiology in Parkinson's Disease and Amyotrophic Lateral Sclerosis JOURNAL OF ALZHEIMERS DISEASE. 2010; 20: S335-S356	0	0	66	204
885	24925 Ewald CY, Li C Understanding the molecular basis of Alzheimer's disease using a Caenorhabditis elegans model system BRAIN STRUCTURE & FUNCTION. 2010 MAR; 214 (2-3): 263-283	0	0	32	204
886	26447 Franco R, Li SM, Rodriguez-Rocha H, Burns M, Panayiotidis MI Molecular mechanisms of pesticide-induced neurotoxicity: Relevance to Parkinson's disease CHEMICO-BIOLOGICAL INTERACTIONS. 2010 NOV 5; 188 (2): 289-300	0	0	26	204
887	1863 WOUTERLOOD FG, GROENEWEGEN HJ THE PHASEOLUS VULGARIS-LEUKOAGGLUTININ TRACING TECHNIQUE FOR THE STUDY OF NEURONAL CONNECTIONS PROGRESS IN HISTOCHEMISTRY AND CYTOCHEMISTRY. 1991; 22 (1): 1-&	1	19	8	203
888	3024 BARNES L, KAPADIA SB THE BIOLOGY AND PATHOLOGY OF SELECTED SKULL BASE TUMORS JOURNAL OF NEURO-ONCOLOGY. 1994; 20 (3): 213-240	1	14	12	203
889	10366 Stevanin G, Durr A, Brice A Spinocerebellar ataxias caused by polyglutamine expansions TRIPLE REPEAT DISEASES OF THE NERVOUS SYSTEMS. 2002; 516: 47-77	1	9	52	203
890	10380 Fuller CE, Perry A Fluorescence in situ hybridization (FISH) in diagnostic and investigative neuropathology BRAIN PATHOLOGY. 2002 JAN; 12 (1): 67-86	0	32	12	203
#	Date / Author / Journal	LCS	GCS	LCR	CR
891	11077 Herrero MT, Barcia C, Navarro JM Functional anatomy of thalamus and basal ganglia CHILDS NERVOUS SYSTEM. 2002 AUG; 18 (8): 386-404	2	72	6	203
892	16541 Horn AKE The reticular formation NEUROANATOMY OF THE OCULOMOTOR SYSTEM. 2006; 151: 127-155	0	7	14	203
893	17245 Larner SF, Hayes RL, Wang KKW Unfolded protein response after neurotrauma JOURNAL OF NEUROTRAUMA. 2006 JUN; 23 (6): 807-829	1	13	18	203
894	19551 Waddington JL, Corvin AP, Donohoe G, O'Tuathaigh CMP, Mitchell KJ, et al. Functional genomics and schizophrenia: Endophenotypes and mutant models PSYCHIATRIC CLINICS OF NORTH AMERICA. 2007 SEP; 30 (3): 365-+	0	12	16	203
895	21880 Rhodes SL, Ritz B Genetics of iron regulation and the possible role of iron in Parkinson's disease NEUROBIOLOGY OF DISEASE. 2008 NOV; 32 (2): 183-195	1	8	19	203
896	23543 Kim SU, de Vellis J Stem Cell-Based Cell Therapy in Neurological Diseases: A Review JOURNAL OF NEUROSCIENCE RESEARCH. 2009 AUG 1; 87 (10): 2183-2200	3	29	25	203
897	26210 Mackenzie IRA, Rademakers R, Neumann M TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia LANCET NEUROLOGY. 2010 OCT; 9 (10): 995-1007	3	4	143	203
898	26630 Pienaar IS, Gotz J, Feany MB Parkinson's disease Insights from non-traditional model organisms PROGRESS IN NEUROBIOLOGY. 2010 DEC; 92 (4): 558-571	0	0	57	203
899	7014 Storey E, Cappai R The amyloid precursor protein of Alzheimer's disease and the A beta peptide NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 1999 APR; 25 (2): 81-97	21	74	33	202
900	8353 De Strooper B, Annaert W Proteolytic processing and cell biological functions of the amyloid precursor protein JOURNAL OF CELL SCIENCE. 2000 JUN; 113 (11): 1857-1870	44	265	24	202

Date / Author / Journal

LCS

GCS

LCR

801

9924 Wong PC, Cai HB, Borchelt DR, Price DL

Genetically engineered models relevant to neurodegenerative disorders - Their value for understanding disease mechanisms and designing/testing experimental therapeutics

JOURNAL OF MOLECULAR NEUROSCIENCE. 2001 OCT; 17 (2): 233-257

211

802

14375 Kontush A

Apolipoprotein A beta: Black sheep in a good family

BRAIN PATHOLOGY. 2004 OCT; 14 (4): 433-447

211

803

16123 Carson RG

Neural pathways mediating bilateral interactions between the upper limbs

BRAIN RESEARCH REVIEWS. 2005 NOV; 49 (3): 641-662

211

804

16536 Lang AE, Houeto JL, Krack P, Kubu C, Lyons KE, et al.

Deep brain stimulation: Preoperative issues

MOVEMENT DISORDERS. 2006; 21: S171-S196

211

805

18422 Thomas P, Fenech M

A review of genome mutation and Alzheimer's disease

MUTAGENESIS. 2007 JAN; 22 (1): 15-33

211

806

21342 Andres RH, Ducraya AD, Schlattner U, Wallimann T, Widmer HR

Functions and effects of creatine in the central nervous system

BRAIN RESEARCH BULLETIN. 2008 JUL 1; 76 (4): 329-343

211

807

21999 Gorman AM

Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2008 DEC; 12 (6A): 2263-2280

211

808

5649 Gasparini L, Racchi M, Binetti G, Trabucchi M, Solerte SB, et al.

Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease

FASEB JOURNAL. 1998 JAN; 12 (1): 17-34

113

210

809

5824 Savitz SI, Rosenbaum DM

Apoptosis in neurological disease

NEUROSURGERY. 1998 MAR; 42 (3): 555-572

210

810

6570 Goodrich LV, Scott MP

Hedgehog and Patched in neural development and disease

NEURON. 1998 DEC; 21 (6): 1243-1257

165

210

Date / Author / Journal

LCS

GCS

LCR

811

7570 Margolis RL, McInnis MG, Rosenblatt A, Ross CA

Trinucleotide repeat expansion and neuropsychiatric disease

ARCHIVES OF GENERAL PSYCHIATRY. 1999 NOV; 56 (11): 1019-1031

210

812

11667 Murthy VN, De Camilli P

Cell biology of the presynaptic terminal

ANNUAL REVIEW OF NEUROSCIENCE. 2003; 26: 701-728

163

210

813

16956 Hodges BL, Cheng SH

Cell and gene-based therapies for the lysosomal storage diseases

CURRENT GENE THERAPY. 2006 APR; 6 (2): 227-241

210

814

17288 Schmidt-Kastner R, van Os J, Steinbusch HWM, Schmitz C

Gene regulation by hypoxia and the neurodevelopmental origin of schizophrenia

SCHIZOPHRENIA RESEARCH. 2006 JUN; 84 (2-3): 253-271

210

815

18284 O'Tuathaigh CMP, Babovic D, O'Meara G, Clifford JJ, Croke DT, et al.

Susceptibility genes for schizophrenia: Characterisation of mutant mouse models at the level of phenotypic behaviour

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2007; 31 (1): 60-78

210

816

18970 Petrukhin K

New therapeutic targets in atrophic age-related macular degeneration

EXPERT OPINION ON THERAPEUTIC TARGETS. 2007 MAY; 11 (5): 625-639

210

817

19485 Hernandez F, Avila J

Tauopathies

CELLULAR AND MOLECULAR LIFE SCIENCES. 2007 SEP; 64 (17): 2219-2233

121

210

818

22518 Vandenbosch R, Borgs L, Beukelaers P, Belachew S, Moonen G, et al.

Adult Neurogenesis and the Diseased Brain

CURRENT MEDICINAL CHEMISTRY. 2009 FEB; 16 (6): 652-666

210

819

26215 Ali YO, Kitay BM, Zhai RG

Dealing with Misfolded Proteins: Examining the Neuroprotective Role of Molecular Chaperones in Neurodegeneration

MOLECULES. 2010 OCT; 15 (10): 6859-6887

210

820

26776 Marschall ALJ, Frenzel A, Schirrmann T, Schungel M, Dubel S

Targeting antibodies to the cytoplasm

MABS. 2011 JAN-FEB; 3 (1): 3-16

210

Date / Author / Journal

821

THE INTERSTITIAL NUCLEUS OF CAJAL AND ITS ROLE IN THE CONTROL OF MOVEMENTS OF HEAD AND EYES

PROGRESS IN NEUROBIOLOGY. 1987; 29 (2): 107-&

148

209

822

3303 DUARTE EA, NOVELLA IS, WEAVER SC, DOMINGO E, WAINHOBSON S, et al.

RNA VIRUS QUASI-SPECIES - SIGNIFICANCE FOR VIRAL DISEASE AND EPIDEMIOLOGY

INFECTIOUS AGENTS AND DISEASE-REVIEWS ISSUES AND COMMENTARY. 1994 AUG; 3 (4): 201-214

209

823

6122 Mastrianni JA

The prion diseases: Creutzfeldt-Jakob, Gerstmann-Straussler-Scheinker, and related disorders

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY. 1998 SUM; 11 (2): 78-97

209

824

9635 Gotz J

Tau and transgenic animal models

BRAIN RESEARCH REVIEWS. 2001 JUL; 35 (3): 266-286

135

209

825

12748 Rensink AAM, de Waal RMW, Kremer B, Verbeek MM

Pathogenesis of cerebral amyloid angiopathy

BRAIN RESEARCH REVIEWS. 2003 OCT; 43 (2): 207-223

209

826

15249 Morris JC

Dementia update 2005

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2005 APR-JUN; 19 (2): 100-117

209

827

20925 Vanlangenakker N, Vanden Berghe T, Krysko DV, Festjens N, Vandenabeele P

Molecular mechanisms and pathophysiology of necrotic cell death

CURRENT MOLECULAR MEDICINE. 2008 MAY; 8 (3): 207-220

209

828

21153 Barten DM, Albright CF

Therapeutic strategies for Alzheimer's disease

MOLECULAR NEUROBIOLOGY. 2008 JUN; 37 (2-3): 171-186

209

829

23150 Berth SH, Leopold PL, Morfini G

Virus-induced neuronal dysfunction and degeneration

FRONTIERS IN BIOSCIENCE. 2009 JUN; 14: 5239-5259

209

830

25120 Hoffner G, Andre W, Vanhoutteghem A, Soues S, Djian P

Transglutaminase-Catalyzed Crosslinking in Neurological Disease: From Experimental Evidence to Therapeutic Inhibition

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 APR; 9 (2): 217-231

209

Date / Author / Journal

LCS

GCS

LCR

831

26243 Hamby ME, Sofroniew MV

Reactive Astrocytes As Therapeutic Targets for CNS Disorders

NEUROTHERAPEUTICS. 2010 OCT; 7 (4): 494-506

209

832

14758 Upadhya SC, Hegde AN

Ubiquitin-proteasome pathway components as therapeutic targets for CNS maladies

CURRENT PHARMACEUTICAL DESIGN. 2005; 11 (29): 3807-3828

208

833

17782 Muller N, Schwarz M

Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission

NEUROTOXICITY RESEARCH. 2006 OCT; 10 (2): 131-148

208

834

18009 McCudden CR, Kraus VB

Biochemistry of amino acid racemization and clinical application to musculoskeletal disease

CLINICAL BIOCHEMISTRY. 2006 DEC; 39 (12): 1112-1130

208

835

21312 Bhidayasiri R, Ling H

Multiple system atrophy

NEUROLOGIST. 2008 JUL; 14 (4): 224-237

208

836

24332 Joers VL, Emborg ME

Preclinical Assessment of Stem Cell Therapies for Neurological Diseases

ILAR JOURNAL. 2010; 51 (1): 24-41

208

837

24503 Krieg R, Halbhuber KJ

Detection of endogenous and immuno-bound peroxidase - The status Quo in histochemistry

PROGRESS IN HISTOCHEMISTRY AND CYTOCHEMISTRY. 2010; 45 (2): 81-139

208

838

25800 Robinson PA

Understanding the molecular basis of Parkinson's disease, identification of biomarkers and routes to therapy

EXPERT REVIEW OF PROTEOMICS. 2010 AUG; 7 (4): 565-578

208

839

531 MIETTINEN M, LEHTO VP, VIRTANEN I

ANTIBODIES TO INTERMEDIATE FILAMENT PROTEINS IN THE DIAGNOSIS AND CLASSIFICATION OF HUMAN-TUMORS

ULTRASTRUCTURAL PATHOLOGY. 1984; 7 (2-3): 83-107

163

207

840

2603 CRUTCHER KA, ANDERTON BH, BARGER SW, OHM TG, SNOW AD

CELLULAR AND MOLECULAR PATHOLOGY IN ALZHEIMERS-DISEASE

HIPPOCAMPUS. 1993; 3: 271-287

207

Date / Author / Journal

841

A REVIEW OF INTERMEDIATE FILAMENT BIOLOGY AND THEIR USE IN PATHOLOGICAL DIAGNOSIS

MOLECULAR BIOLOGY REPORTS. 1994 JAN; 19 (1): 3-21

207

842

3140 AVILA J, DOMINGUEZ J, DIAZNIDO J

REGULATION OF MICROTUBULE DYNAMICS BY MICROTUBULE-ASSOCIATED PROTEIN EXPRESSION AND PHOSPHORYLATION DURING NEURONAL DEVELOPMENT

INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY. 1994 MAR; 38 (1): 13-25

121

207

843

9995 Morley KI, Montgomery GW

The genetics of cognitive processes: Candidate genes in humans and animals

BEHAVIOR GENETICS. 2001 NOV; 31 (6): 511-531

207

844

12661 Batchelor PE, Howells DW

CNS regeneration: clinical possibility or basic science fantasy?

JOURNAL OF CLINICAL NEUROSCIENCE. 2003 SEP; 10 (5): 523-534

207

845

14892 Aksenova MV, Aksenov MY, Mactutus CF, Booze RM

Cell culture models of oxidative stress and injury in the central nervous system

CURRENT NEUROVASCULAR RESEARCH. 2005 JAN; 2 (1): 73-89

207

846

17785 Williams BJ, Eriksdotter-Jonhagen M, Granholm AC

Nerve growth factor in treatment and pathogenesis of Alzheimer's disease

PROGRESS IN NEUROBIOLOGY. 2006 OCT; 80 (3): 114-128

207

847

22984 Le Strat Y, Ramoz N, Gorwood P

The Role of Genes Involved in Neuroplasticity and Neurogenesis in the Observation of a Gene-Environment Interaction (GxE) in Schizophrenia

CURRENT MOLECULAR MEDICINE. 2009 MAY; 9 (4): 506-518

207

848

1992 MARGOLIN DI

COGNITIVE NEUROPSYCHOLOGY - RESOLVING ENIGMAS ABOUT WERNICKES APHASIA AND OTHER HIGHER CORTICAL DISORDERS

ARCHIVES OF NEUROLOGY. 1991 JUL; 48 (7): 751-765

206

849

3307 MANI S, MODLIN IM, BALLANTYNE G, AHLMAN H, WEST B

CARCINOIDS OF THE RECTUM

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. 1994 AUG; 179 (2): 231-248

206

850

14062 Gotz J, Streffer JR, David D, Schild A, Hoerndli F, et al.

Transgenic animal models of Alzheimer's disease and related disorders: Histopathology, behavior and therapy

MOLECULAR PSYCHIATRY. 2004 JUL; 9 (7): 664-683

101

206

Date / Author / Journal

LCS

GCS

LCR

851

16862 Fleischer A, Ghadiri A, Dessauge F, Duhamel M, Rebollo MP, et al.

Modulating apoptosis as a target for effective therapy

MOLECULAR IMMUNOLOGY. 2006 MAR; 43 (8): 1065-1079

206

852

20202 Dohm CP, Kermer P, Bahr M

Aggregopathy in neurodegenerative diseases: Mechanisms and therapeutic implication

NEURODEGENERATIVE DISEASES. 2008; 5 (6): 321-338

206

853

20629 Sakakibara R, Uchiyama T, Yamanishi T, Shirai K, Hattori T

Bladder and bowel dysfunction in Parkinson's disease

JOURNAL OF NEURAL TRANSMISSION. 2008 MAR; 115 (3): 443-460

206

854

21098 Venugopal C, Demos CM, Rao KSJ, Pappolla MA, Sambamurti K

Beta-Secretase: Structure, Function, and Evolution

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2008 JUN; 7 (3): 278-294

206

855

21355 Singh M, Arseneault M, Sanderson T, Murthy V, Ramassamy C

Challenges for research on polyphenols from foods in Alzheimer's disease: Bioavailability, metabolism, and cellular and molecular mechanisms

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY. 2008 JUL 9; 56 (13): 4855-4873

206

856

24908 Delcroix GJR, Schiller PC, Benoit JP, Montero-Menei CN

Adult cell therapy for brain neuronal damages and the role of tissue engineering

BIOMATERIALS. 2010 MAR; 31 (8): 2105-2120

206

857

24918 Luebke J, Barbas H, Peters A

Effects of normal aging on prefrontal area 46 in the rhesus monkey

BRAIN RESEARCH REVIEWS. 2010 MAR; 62 (2): 212-232

206

858

26600 Rupprecht R, Papadopoulos V, Rammes G, Baghai TC, Fan JJ, et al.

Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders

NATURE REVIEWS DRUG DISCOVERY. 2010 DEC; 9 (12): 971-988

206

859

6078 Bischoff KM, Shi L, Kennelly PJ

The detection of enzyme activity following sodium dodecyl sulfate- polyacrylamide gel electrophoresis

ANALYTICAL BIOCHEMISTRY. 1998 JUN 15; 260 (1): 1-17

205

860

10210 Herz J, Bock HH

Lipoprotein receptors in the nervous system

ANNUAL REVIEW OF BIOCHEMISTRY. 2002; 71: 405-434

192

205

Date / Author / Journal

LCS

GCS

LCR

861

11688 Festoff BW, Suo ZM, Citron BA

Prospects for the pharmacotherapy of amyotrophic lateral sclerosis - Old strategies and new paradigms for the third millennium

CNS DRUGS. 2003; 17 (10): 699-717

205

862

11718 Schallert T, Woodlee MT, Fleming SM

Experimental focal ischemic injury: Behavior-brain interactions and issues of animal handling and housing

ILAR JOURNAL. 2003; 44 (2): 130-143

205

863

12646 Uversky VN

Protein folding revisited. A polypeptide chain at the folding- misfolding-nonfolding cross-roads: which way to go?

CELLULAR AND MOLECULAR LIFE SCIENCES. 2003 SEP; 60 (9): 1852-1871

102

205

864

17720 Kyttala A, Lahtinen U, Braulke T, Hofmann SL

Functional biology of the neuronal ceroid lipofuscinoses (NCL) proteins

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2006 OCT; 1762 (10): 920-933

205

865

18651 Hunter RL, Bing GY

Agonism of peroxisome proliferator receptor-gamma may have therapeutic potential for neuroinflammation and Parkinson's disease

CURRENT NEUROPHARMACOLOGY. 2007 MAR; 5 (1): 35-46

205

866

23924 Bulat N, Widmann C

Caspase substrates and neurodegenerative diseases

BRAIN RESEARCH BULLETIN. 2009 OCT 28; 80 (4-5): 251-267

205

867

26786 Scherder E, Eggermont L, Visscher C, Scheltens P, Swaab D

Understanding higher level gait disturbances in mild dementia in order to improve rehabilitation: 'Last in-first out'

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2011 JAN; 35 (3): 699-714

205

868

1826 SKALLI O, GOLDMAN RD

RECENT INSIGHTS INTO THE ASSEMBLY, DYNAMICS, AND FUNCTION OF INTERMEDIATE FILAMENT NETWORKS

CELL MOTILITY AND THE CYTOSKELETON. 1991; 19 (2): 67-79

155

204

869

2628 FREED WJ

NEURAL TRANSPLANTATION - PROSPECTS FOR CLINICAL USE

CELL TRANSPLANTATION. 1993 JAN-FEB; 2 (1): 13-31

204

870

6860 Peckys D, Landwehrmeyer GB

Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: A P-33 in situ hybridization study

NEUROSCIENCE. 1999 FEB; 88 (4): 1093-1135

204

Date / Author / Journal

LCS

GCS

LCR

871

8797 Alisky JM, Davidson BL

Gene therapy for amyotrophic lateral sclerosis and other motor neuron diseases

HUMAN GENE THERAPY. 2000 NOV; 11 (17): 2315-2329

204

872

10786 Okereke CS

Role of integrative pharmacokinetic and pharmacodynamic optimization strategy in the management of Parkinson's disease patients experiencing motor fluctuations with levodopa.

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES. 2002 MAY-AUG; 5 (2): 146-161

204

873

11810 Stein TD, Johnson JA

Genetic programming by the proteolytic fragments of the amyloid precursor protein: Somewhere between confusion and clarity

REVIEWS IN THE NEUROSCIENCES. 2003; 14 (4): 317-341

204

874

12744 Czyz J, Wiese C, Rolletschek A, Blyszczuk P, Cross M, et al.

Potential of embryonic and adult stem cells in vitro

BIOLOGICAL CHEMISTRY. 2003 OCT-NOV; 384 (10-11): 1391-1409

204

875

12772 Uversky VN

A protein-chameleon: Conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS. 2003 OCT; 21 (2): 211-234

140

204

876

13091 Riddle R, Pollock JD

Making connections: the development of mesencephalic dopaminergic neurons

DEVELOPMENTAL BRAIN RESEARCH. 2003 DEC 30; 147 (1-2): 3-21

204

877

14204 Haddad JJ

Mitogen-activated protein kinases and the evolution of Alzheimer's: a revolutionary neurogenetic axis for therapeutic intervention?

PROGRESS IN NEUROBIOLOGY. 2004 AUG; 73 (5): 359-377

204

878

14725 Hughes CE, Baldus M

Magic-angle-spinning solid-state NMR applied to polypeptides and proteins

ANNUAL REPORTS ON NMR SPECTROSCOPY, VOL 55. 2005; 55: 121-158

204

879

17870 Barber SC, Mead RJ, Shaw PJ

Oxidative stress in ALS: A mechanism of neurodegeneration and a therapeutic target

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2006 NOV-DEC; 1762 (11-12): 1051-1067

204

880

20388 Adibhatla RM, Dempsy R, Hatcher JF

Integration of cytokine biology and lipid metabolism in stroke

FRONTIERS IN BIOSCIENCE. 2008 JAN 1; 13: 1250-1270

204

Date / Author / Journal

LCS

GCS

LCR

881

21682 Ono K, Hirohata M, Yamada M

alpha-Synuclein Assembly as a Therapeutic Target of Parkinson's Disease and Related Disorders

CURRENT PHARMACEUTICAL DESIGN. 2008 OCT; 14 (30): 3247-3266

204

882

22331 Kang SS, McGavern DB

Inflammation on the Mind: Visualizing Immunity in the Central Nervous System

VISUALIZING IMMUNITY. 2009; 334: 227-263

204

883

22432 Schwartz EI

Potential application of RNAi for understanding and therapy of neurodegenerative diseases

FRONTIERS IN BIOSCIENCE. 2009 JAN 1; 14: 297-320

204

884

24370 Martin LJ

Mitochondrial Pathobiology in Parkinson's Disease and Amyotrophic Lateral Sclerosis

JOURNAL OF ALZHEIMERS DISEASE. 2010; 20: S335-S356

204

885

24925 Ewald CY, Li C

Understanding the molecular basis of Alzheimer's disease using a Caenorhabditis elegans model system

BRAIN STRUCTURE & FUNCTION. 2010 MAR; 214 (2-3): 263-283

204

886

26447 Franco R, Li SM, Rodriguez-Rocha H, Burns M, Panayiotidis MI

Molecular mechanisms of pesticide-induced neurotoxicity: Relevance to Parkinson's disease

CHEMICO-BIOLOGICAL INTERACTIONS. 2010 NOV 5; 188 (2): 289-300

204

887

1863 WOUTERLOOD FG, GROENEWEGEN HJ

THE PHASEOLUS VULGARIS-LEUKOAGGLUTININ TRACING TECHNIQUE FOR THE STUDY OF NEURONAL CONNECTIONS

PROGRESS IN HISTOCHEMISTRY AND CYTOCHEMISTRY. 1991; 22 (1): 1-&

203

888

3024 BARNES L, KAPADIA SB

THE BIOLOGY AND PATHOLOGY OF SELECTED SKULL BASE TUMORS

JOURNAL OF NEURO-ONCOLOGY. 1994; 20 (3): 213-240

203

889

10366 Stevanin G, Durr A, Brice A

Spinocerebellar ataxias caused by polyglutamine expansions

TRIPLE REPEAT DISEASES OF THE NERVOUS SYSTEMS. 2002; 516: 47-77

203

890

10380 Fuller CE, Perry A

Fluorescence in situ hybridization (FISH) in diagnostic and investigative neuropathology

BRAIN PATHOLOGY. 2002 JAN; 12 (1): 67-86

203

Date / Author / Journal

LCS

GCS

LCR

891

11077 Herrero MT, Barcia C, Navarro JM

Functional anatomy of thalamus and basal ganglia

CHILDS NERVOUS SYSTEM. 2002 AUG; 18 (8): 386-404

203

892

16541 Horn AKE

The reticular formation

NEUROANATOMY OF THE OCULOMOTOR SYSTEM. 2006; 151: 127-155

203

893

17245 Larner SF, Hayes RL, Wang KKW

Unfolded protein response after neurotrauma

JOURNAL OF NEUROTRAUMA. 2006 JUN; 23 (6): 807-829

203

894

19551 Waddington JL, Corvin AP, Donohoe G, O'Tuathaigh CMP, Mitchell KJ, et al.

Functional genomics and schizophrenia: Endophenotypes and mutant models

PSYCHIATRIC CLINICS OF NORTH AMERICA. 2007 SEP; 30 (3): 365-+

203

895

21880 Rhodes SL, Ritz B

Genetics of iron regulation and the possible role of iron in Parkinson's disease

NEUROBIOLOGY OF DISEASE. 2008 NOV; 32 (2): 183-195

203

896

23543 Kim SU, de Vellis J

Stem Cell-Based Cell Therapy in Neurological Diseases: A Review

JOURNAL OF NEUROSCIENCE RESEARCH. 2009 AUG 1; 87 (10): 2183-2200

203

897

26210 Mackenzie IRA, Rademakers R, Neumann M

TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia

LANCET NEUROLOGY. 2010 OCT; 9 (10): 995-1007

143

203

898

26630 Pienaar IS, Gotz J, Feany MB

Parkinson's disease Insights from non-traditional model organisms

PROGRESS IN NEUROBIOLOGY. 2010 DEC; 92 (4): 558-571

203

899

7014 Storey E, Cappai R

The amyloid precursor protein of Alzheimer's disease and the A beta peptide

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 1999 APR; 25 (2): 81-97

202

900

8353 De Strooper B, Annaert W

Proteolytic processing and cell biological functions of the amyloid precursor protein

JOURNAL OF CELL SCIENCE. 2000 JUN; 113 (11): 1857-1870

265

202

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records